Logo image
Back
Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma
Journal article   Peer reviewed

Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma

Ahmed I. Tahseen and Neel B. Patel
JAAD Case Reports, Vol.4(9), pp.930-933
10/01/2018
DOI: https://doi.org/10.1016/j.jdcr.2018.08.003
PMID: 30320198

Abstract

allergic reaction antitumor response antitumor response toxic epidermal necrolysis BRAF inhibitor BRAF inhibitor Stevens-Johnson syndrome BRAF inhibitor toxic epidermal necrolysis coBRIM adverse effect coBRIM allergic reaction coBRIM hypersensitivity cross-reactivity dabrafenib dabrafenib toxic epidermal necrolysis dabrafenib vemurafenib dabrafenib vemurafenib switch hypersensitivity lymphocyte transformation test Stevens-Johnson syndrome lymphocyte transformation test toxic epidermal necrolysis melanoma metastatic melanoma Stevens-Johnson syndrome Stevens-Johnson syndrome desensitization sulfonamide sulfonamide cross-reactivity sulfonamide drug sulfonamide toxic epidermal necrolysis toxic epidermal necrolysis toxic epidermal necrolysis desensitization toxic epidermal necrolysis/Stevens-Johnson syndrome vemurafenib vemurafenib adverse effect vemurafenib allergic reaction vemurafenib dabrafenib cross-reactivity vemurafenib hypersensitivity vemurafenib toxic epidermal necrolysis
url
https://doi.org/10.1016/j.jdcr.2018.08.003View
Published (Version of record) Open

Metrics

1 Record Views

Details

Logo image